XLVvsBMEDETF Comparison
VS
State Street Health Care Select Sector SPDR ETF (XLV) belongs to the US Health Care segment. iShares Health Innovation Active ETF (BMED) is part of the Healthcare Technology segment. XLV's top 3 sector exposures are Healthcare and Consumer Non-Cyclicals. In contrast, BMED's top sector exposures are Healthcare and Non-Corporate. XLV is less expensive with a Total Expense Ratio (TER) of 0.08%, versus 0.77% for BMED. XLV is up 3.84% year-to-date (YTD) with +$943M in YTD flows. BMED performs worse with 1.7% YTD performance, and +$4M in YTD flows. Run a side-by-side ETF comparison of XLV and BMED below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
XLV vs BMED performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 07/22/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | XLV BMED | +6.19%+4.43% | +9.37%+9.15% | +3.84%+1.70% | +21.40%+20.98% | +23.25%+25.40% | +33.00%+4.73% |
| Flows | XLV BMED | +$1.12B- | -$467M- | +$943M+$4M | +$2.38B+$6M | -$5.28B+$4M | +$3.47B+$5M |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | XLV BMED | +18.37%+17.47% | +15.76%+16.01% | +14.31%+16.05% | +14.97%+17.72% |
| Max drawdown | XLV BMED | -3.83%-4.62% | -10.51%-14.71% | -17.05%-19.76% | -17.05%-33.96% |
| Max drawdown duration | XLV BMED | 15d19d | 116d183d | 444d237d | 444d1586d |
Trading data
XLV | BMED | |
Last sale 7/24/2026 at 1:30 PM | $162.57 | $30.73 |
| Previous close 07/23/2026 | $161.44 | $30.76 |
| Consolidated volume 07/23/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of June 30, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
BMED
is actively managed and doesn’t replicate an indexXLV | BMED | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 7/24/2026 at 1:30 PM
Live
Closed
XLV | BMED | |
|---|---|---|
| Last price | $162.57 | $30.73 |
| 1D performance | +0.70% | -0.09% |
| AuM | $41.69 B | $11.06 M |
| E/R | 0.08% | 0.77% |
Characteristics
XLV | BMED | |
|---|---|---|
| Management strategy | Passive | Active |
| Provider | State Street Investment Management | iShares |
| Benchmark | S&P Health Care Select Sector Index | - |
| N° of holdings | 59 | 52 |
| Asset class | Equities | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | December 16, 1998 | September 29, 2020 |
| ESG | No | No |
Advertisement
Exposure
Countries
XLV
USA
97.92%
Other
2.08%
BMED
USA
88.93%
Other
11.07%
Sectors
XLV
Healthcare
97.73%
Other
2.27%
BMED
Healthcare
97.21%
Other
2.79%
Diversification
XLV
Total weight of top 15 holdings out of 15
72.82%
BMED
Total weight of top 15 holdings out of 15
59.83%
Top 15 holdings
Data as of June 30, 2026
XLV
Eli Lilly & Co.
16.57%
Johnson & Johnson
10.68%
AbbVie, Inc.
7.76%
UnitedHealth Group, Inc.
6.59%
Merck & Co., Inc.
5.54%
Amgen, Inc.
3.41%
Thermo Fisher Scientific, Inc.
3.25%
Abbott Laboratories
2.76%
Gilead Sciences, Inc.
2.74%
Intuitive Surgical, Inc.
2.46%
Pfizer Inc.
2.40%
CVS Health Corp.
2.31%
Vertex Pharmaceuticals, Inc.
2.20%
Danaher Corp.
2.10%
Bristol Myers Squibb Co.
2.05%
BMED
Merck & Co., Inc.
5.90%
Johnson & Johnson
5.13%
Gilead Sciences, Inc.
4.77%
Edwards Lifesciences Corp.
4.70%
BlackRock Cash Funds - Treasury
4.08%
Biogen, Inc.
3.79%
Moderna, Inc.
3.78%
Thermo Fisher Scientific, Inc.
3.69%
Charles River Laboratories International, Inc.
3.67%
Danaher Corp.
3.59%
Waters Corp.
3.52%
AbbVie, Inc.
3.49%
Amgen, Inc.
3.44%
Mettler-Toledo International, Inc.
3.17%
Vertex Pharmaceuticals, Inc.
3.11%
Frequently asked questions about XLV and BMED
How have the XLV and BMED ETFs performed in 2026?
As of July 22, 2026, XLV is up 3.84% year-to-date (YTD), while BMED has returned 1.7%. That puts XLV better performer ahead so far this year.
Which ETF is attracting more investor money: XLV or BMED?
Year-to-date, the XLV ETF saw +$943M in flows, compared to +$4M for BMED.
Which ETF is more volatile: XLV or BMED?
Over the past year, XLV had a volatility of 15.76%, while BMED experienced 16.01%.
Which ETF is bigger: XLV or BMED?
As of July 22, 2026, XLV holds $41.69 B in assets under management (AUM), while BMED manages $11.06 M.
What sectors do the XLV and BMED ETFs invest in?
XLV leans toward sectors like Healthcare. Meanwhile, BMED focuses on Healthcare.
What are the top holdings of the XLV ETF and BMED ETF?
XLV top holdings include Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc.. BMED holds in its top three: Merck & Co., Inc., Johnson & Johnson and Gilead Sciences, Inc..
Which ETF is more diversified: XLV or BMED?
XLV holds 59 securities with 72.82% of its assets in the top 15. BMED has 55 securities and a top 15 weight of 59.83%.
Advertisement
Latest news about XLV & BMED
ETF Model Portfolios: The Cockroach Portfolio
March 20, 2026
XLV
ETF Central's Guide to Defensive Sector Investing
March 13, 2026
XLV
Chinese Artificial Intelligence (AI) DeepSeek: ETF Winners & Losers
January 27, 2025
XLV
Investing in Sector ETFs: Consumer Staples, Healthcare, & Utilities
August 21, 2024
XLV
Advertisement
Healthcare Stocks Drop on Medicare Payment Rate Surprise
April 8, 2024
XLV
Healthcare Stocks Drop on Medicare Payment Rate Surprise
April 8, 2024
XLV
Advertisement
